Skip to main content
. 2019 Jun 25;144(1):79–87. doi: 10.1007/s11060-019-03228-6

Fig. 4.

Fig. 4

Tumors of LGG patients do not harbor CD4 T cell reactivity against IDH1R132H. TILs were obtained as described and expanded from fresh LGG tumor fragments in IL-2 supplemented medium during 2 weeks. TILs were then stimulated with IDH1R132H or IDH1WT peptide-loaded, irradiated autologous PBMC for 16 h (n = 10 patients). a Percentage of CD137+ cells of CD4+ T cells. b IFN-γ response of the same TIL populations as in (a). Each dot represents an individual patient sample. IDH1R132H and IDH1WT were corrected for the medium values